Concepedia

Author

Anton Leighton

University of Colorado Health

Also Known As

A. Leighton, ANTON LEIGHTON, Anton Leighton, C. Berkowicz, R. Rossaint

16

Publications

963

Citations

9

H-Index

29

Concepts

All Affiliations

University of Colorado HealthTrellis Bioscience (United States)Menlo SchoolSouthern Illinois University School of MedicineUniversity of California, Los Angeles
AL

About

Anton Leighton is an author at University of Colorado Health specializing in antimicrobial resistance, medicine, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

302

2

Health Sciences

2

2

268

3

Arts

1

1

34

4

Biomedical Engineering

1

1

81

5

Microbiology

1

1

81

Anton Leighton

×

9

Publications

960

Citations

9

H-Index

YearCitations

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

Edward Abraham, Pierre-François Laterre, Jorge Garbino,

Critical Care Medicine

2001

291

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Edward Abraham, Konrad Reinhart, Petr Svoboda,

Critical Care Medicine

2001

252

Tolerability, Pharmacokinetics, and Serum Bactericidal Activity of Intravenous Dalbavancin in Healthy Volunteers

Anton Leighton, Alice B. Gottlieb, Daniela Jabés,

Antimicrobial Agents and Chemotherapy

2004

187

A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model

Angeles Estellés, Anne-Kathrin Woischnig, Keyi Liu,

Antimicrobial Agents and Chemotherapy

2016

81

A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections

Yan Q. Xiong, Angeles Estellés, Liang Li,

Antimicrobial Agents and Chemotherapy

2017

57

Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis

Didier Pittet, Stephan Harbarth, Peter M. Suter,

American Journal of Respiratory and Critical Care Medicine

1999

36

Audiologic Monitoring for Potential Ototoxicity in a Phase I Clinical Trial of a New Glycopeptide Antibiotic

Kathleen C. M. Campbell, Ellen Kelly, Nan Targovnik,

Journal of the American Academy of Audiology

2003

34

Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip

Janet D. Conway, Ronald E. Delanois, Michael A. Mont,

Antimicrobial Agents and Chemotherapy

2024

12

The pharmacokinetics and renal excretion of dalbavancin in healthy subjects

James A. Dowell, Alice B. Gottlieb, Claudia Van Saders,

Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy

2002

10

Page 1